LACTOSE (INDIA)
Back to Cashflow Statement
|
LACTOSE (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-5.75 Cr | ₹-8.32 Cr | ₹-8.14 Cr | ₹4.52 Cr | ₹-3.57 Cr |
What is the latest Cash Flow from Financing Activities ratio of LACTOSE (INDIA) ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-5.75 Cr |
Mar2023 | ₹-8.32 Cr |
Mar2022 | ₹-8.14 Cr |
Mar2021 | ₹4.52 Cr |
Mar2020 | ₹-3.57 Cr |
How is Cash Flow from Financing Activities of LACTOSE (INDIA) Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-5.75 Cr | Negative | |
Mar2023 | ₹-8.32 Cr | Negative | |
Mar2022 | ₹-8.14 Cr | Negative | |
Mar2021 | ₹4.52 Cr | Positive | |
Mar2020 | ₹-3.57 Cr | - |
Compare Cash Flow from Financing Activities of peers of LACTOSE (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LACTOSE (INDIA) | ₹122.1 Cr | -4.4% | -18.5% | -27.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,865.0 Cr | 0.2% | -8.3% | 15.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,574.0 Cr | -1.9% | 8.6% | 55.9% | Stock Analytics | |
CIPLA | ₹118,710.0 Cr | -1.3% | -5.5% | -0.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,964.0 Cr | -0.5% | -4.2% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,232.0 Cr | 0.7% | 5.8% | 6.1% | Stock Analytics |
LACTOSE (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LACTOSE (INDIA) | -4.4% |
-18.5% |
-27.7% |
SENSEX | -1% |
1.4% |
7.9% |
You may also like the below Video Courses